Brazil’s $4.6 Billion Supplement Market: A Pharmacist’s Breakdown for International Brands

By Wagner Fernandes, Licensed Pharmacist (CRF-RO 4509) · Brazil Market Insights · Updated August 2026
Wagner Fernandes, Pharmacist
Wagner Fernandes · CRF-RO 4509Licensed Pharmacist, Brazil · Founder, FarmaCerto

Brazil’s supplement market, in one paragraph

Brazil’s dietary supplement and sports nutrition market was valued at approximately $4.6 billion USD in 2024, growing around 10% annually through 2030. It’s Latin America’s largest fitness market and the second largest globally by number of gyms, with over 34,000 fitness centers. The regulatory pathway runs through ANVISA under RDC 243/2018, and most standard supplements follow notification, not full registration, contrary to what many international brands assume going in.

$4.6B
Market size, 2024 (USD)
~10%
Annual growth through 2030
34,000+
Fitness centers in Brazil
#2
Globally by gym count

Why Brazil, and why now

Three factors are converging to make Brazil one of the more attractive supplement markets for international brands right now. First, a large, health-conscious population increasingly willing to spend on wellness and performance nutrition, in a country with the second-highest gym count in the world. Second, an e-commerce infrastructure mature enough to support direct-to-consumer entry without requiring a full retail buildout on day one. Third, a regulatory environment that, while genuinely complex, is more navigable through the notification pathway than most international directors initially assume.

Opportunity extends beyond finished consumer products, protein powders, creatine, vitamins, and performance supplements, to include high-quality raw ingredients used by Brazilian manufacturers, such as whey protein isolates, amino acids, and nutraceutical compounds.

Where demand concentrates

CategoryDemand driver
Sports nutrition (protein, creatine)Largest fitness market in Latin America, strong gym culture, 34,000+ facilities
Raw ingredients (whey isolate, amino acids)Brazilian manufacturers sourcing high-quality inputs domestically and via import
Vitamins and multivitamins4-6% CAGR, outpacing the broader supplement category
Functional and clinical nutritionAging population, rising self-diagnosed nutritional gap awareness

The regulatory pathway, in practical terms

ANVISA (Agência Nacional de Vigilância Sanitária) is Brazil’s health regulatory agency. Dietary supplements are classified under RDC 243/2018, which defines “suplemento alimentar” (food supplement) as a product for oral ingestion intended to supplement the diet of healthy individuals with nutrients, bioactive substances, enzymes, or probiotics.

Notification (Risk 1)

Most standard supplements, using ingredients already on ANVISA’s approved list under IN 28/2018, follow this simpler notification pathway before market entry. No pre-approval wait required, but the notification must be complete and accurate.

Registration (Risk 2)

Higher-risk products, novel ingredients, or those not on the pre-approved list, require formal registration with ANVISA before sale, a more complex and longer process.

📋 Regulatory Framework

What actually governs the process

The key regulations to know: RDC 243/2018 (health, safety, and labeling requirements), IN 28/2018 (approved ingredient lists, usage limits, and permitted claims), RDC 843/2024 and IN 281/2024 (updated food registration framework), and IN 373/2025 (most recent update to approved ingredients and labeling requirements). Brands relying on older summaries of Brazilian supplement law risk working from outdated information, since these instructions are revised regularly.

⚠️ The claim that trips up most international brandsSupplements under RDC 243/2018 cannot claim to treat, cure, or prevent disease. A label or marketing claim that crosses this line can trigger reclassification as a pharmaceutical product, which requires a substantially more complex, slower, and expensive registration pathway. This is the single most common compliance mistake we see from brands translating U.S. marketing copy directly into Portuguese.

What a foreign brand actually needs

A company cannot simply ship product into Brazil and sell directly. A legally registered local entity is required to be responsible for importation, distribution, and post-market surveillance. Depending on the product category, an AFE (Autorização de Funcionamento de Empresa, or company operating authorization) may be required. Labeling must be in Portuguese, compliant with IN 28/2018’s nutrient limits, serving guidelines, and permitted claim language, not simply a translated version of the U.S. label.

From the pharmacy counterWhat I see on the consumer side, daily, is real demand outpacing what’s currently well-served in Portuguese. Brazilian consumers research supplement brands extensively online before buying, comparing ingredients, reading about safety, checking whether a product is legitimate. Much of that search volume isn’t being met by structured, trustworthy content from the brands themselves, it’s filled instead by forums, resellers, and generic listicles. That gap, not just regulatory approval, is where the real opportunity sits for a brand willing to invest in it properly.

Full guide: Entering the Brazilian market

For a complete breakdown of ANVISA requirements, local representation, labeling compliance, and how content strategy fits into a successful Brazil market entry, see our complete guide.

Read the Full Brazil Market Entry Guide →

Frequently Asked Questions

Approximately $4.6 billion USD in 2024, projected to grow around 10% annually through 2030, according to U.S. Commercial Service market intelligence. Brazil is Latin America’s largest fitness market and the second largest globally by number of gyms.
No. Under RDC 243/2018, most standard dietary supplements follow a notification pathway (risk classification 1), not full registration. Higher-risk or novel ingredients may require formal registration (risk classification 2).
RDC 243/2018 is ANVISA’s primary resolution establishing health, safety, composition, and labeling requirements for dietary supplements (suplementos alimentares) in Brazil, published July 26, 2018.
No. Supplements classified under RDC 243/2018 cannot claim to treat, cure, or prevent disease. Making such a claim can trigger reclassification as a pharmaceutical product, requiring a substantially more complex registration pathway.
A legally registered company in Brazil responsible for importation, distribution, and post-market surveillance, an AFE where applicable, and Portuguese-language labeling compliant with ANVISA and IN 28/2018 requirements.

References: ANVISA RDC No. 243/2018, “Requisitos Sanitários dos Suplementos Alimentares,” July 26, 2018. Normative Instruction (IN) No. 28/2018, approved constituent lists and labeling. RDC 843/2024 and IN 281/2024, food registration framework. IN 373/2025, updated ingredient and labeling rules. U.S. Commercial Service, “Brazil Dietary Supplements and Sports Nutrition” market intelligence, 2026. BlueWeave Consulting, Brazil Nutritional Supplements Market Report.


Descubra mais sobre FarmaCerto

Assine para receber nossas notícias mais recentes por e-mail.

Deixe um comentário

O seu endereço de e-mail não será publicado. Campos obrigatórios são marcados com *